PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
10-Oct-2023 Pheon Therapeutics Appoints Oncology Expert Arvin Yang, MD, PhD as Chief Medical Officer Pheon Therapeutics
10-Oct-2023 Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award Novotech
10-Oct-2023 LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND AS ADJUVANT TREATMENT FOR PATIENTS WITH GERMLINE BRCA-MUTATED HER2-NEGATIVE HIGH RISK EARLY BREAST CANCER AstraZeneca
10-Oct-2023 Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies Cryoport, Inc
10-Oct-2023 Nobias Therapeutics Announces Phase 2 Clinical Trial Results for NB-001 at 52nd Child Neurology Society Annual Meeting Nobias Therapeutics
10-Oct-2023 Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer’s disease Brandon Capital
10-Oct-2023 PharmEnable Therapeutics and Sosei Heptares Expand Drug Discovery Collaboration PharmEnable Therapeutics
10-Oct-2023 Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications Creative Diagnostics
10-Oct-2023 Creative Diagnostics Launches Checkerboard Assay Services Creative Diagnostics
10-Oct-2023 Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development Creative Diagnostics
06-Oct-2023 ACROMETA's Life Science Incubator (LSI) Signs Agreement with Ho Bee Land subsidiary to operate Co-Working Laboratory AcroMeta Group Limited
06-Oct-2023 Terumo Blood and Cell Technologies launches study with BioCentriq(R) to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platforms Terumo Blood and Cell Technologies
05-Oct-2023 Sharp acquires Berkshire Sterile Manufacturing Sharp
05-Oct-2023 Veranova Announces Appointment of New Advisory Board Veranova
05-Oct-2023 Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19 Moderna
04-Oct-2023 CTMC partners with ScaleReady to automate, close, and scale for greater patient accessibility ScaleReady
04-Oct-2023 PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation PureTech Health plc
04-Oct-2023 Foghorn Therapeutics to Present Clinical and Pre-Clinical Data from Multiple Programs Across Its Diverse Pipeline at AACR-NCI-EORTC International Conference Foghorn Therapeutics
04-Oct-2023 Myricx Expands its ADC Expertise with the Appointment of Francesca Zammarchi as CSO Myricx
04-Oct-2023 IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting IO Biotech